Fluticasone Nasal Spray Patient Preference Study

A Patient Preference Evaluation Study of Fluticasone Furoate Nasal Spray and Fluticasone Propionate Aqueous Nasal Spray in Subject With Allergic Rhinitis

The objectives of this study are to evaluate and compare patient preference for FF (Fluticasone Furoate) and FP (Fluticasone Propionate Aqueous)nasal sprays in the treatment of allergic rhinitis following single-dose administration.

Inclusion Criteria:

• allergic rhinitis
• literate

Exclusion Criteria:

• clinical significant uncontrolled disease
• Use of intranasal corticosteroids (<4 weeks of FP [branded or generic],<4 week exposure to FF, <4 weeks use of other INS)
• Use of intranasal medications <1 week
• Use of meds that significantly inhibit CYP4503A4
• Use of perfume or oral rinse on study day
• Allergy/intolerance to INS, antihistamines, or excipients
• Positive pregnancy test or female who is breastfeeding
• Affiliation with investigational site